Get started
Author

Jiayu Pei

Observed name: J Y Pei
ORCID: 0009-0005-5527-082X
Observed ORCID: 0009-0005-5527-082X
OpenAlex ID: A5111098155
Low pre-treatment neutrophil-to-lymphocyte ratio predicted a better survival in recurrent/metastatic cervical cancer treated with PD-1/PD-L1 inhibitors
2025 · Jing Li, Yulu Wang, et al. · Discover Oncology · 2
PDF
Inflammatory biomarker-based prognostic model for immunotherapy outcomes in patients with recurrent or metastatic cervical cancer.
2026 · Yulu Wang, Jing Li, et al. · Journal of Clinical Oncology
Inflammatory biomarker-based prognostic model for immunotherapy outcomes in patients with recurrent or metastatic cervical cancer
2026 · Yulu Wang, Chengyang Luo, et al. · Frontiers in Oncology
PDF
The Contribution and Perspectives of Proteomics to Epithelial Ovarian Cancer
2025 · Jiayu Pei, Haifeng Qiu, et al. · PROTEOMICS - CLINICAL APPLICATIONS
[Risk prediction of metabolic syndrome and coronary artery disease in overweight and obese populations based on serum metabolomics].
2023 · J Y Pei, D D Zhang, et al. · PubMed
Works count: 5
Citation count: 2
H-index: 1
I10-index:
Year
Topic
Type